Home › Therapeutic areas › Oncology › Pediatric Solid Tumors
Pediatric Solid Tumors (2 companies)
Companies with an active program in Pediatric Solid Tumors.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ACTU | Actuate Therapeutics | Oncology | 2 | Phase 2 | $7.9M | 4 |
| INBX | Inhibrx Biosciences | Oncology | 1 | NDA Submitted | $1.24B | 6 |
No companies match.